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Abstract
The role of the maternal immune system during pregnancy has focused mainly on the aspect of
immune tolerance to the invading trophoblast and, therefore, fetus. While this is a critical aspect
of reproductive immunology, it is also important to consider the function of the maternal immune
system in the promotion of implantation and maintenance of pregnancy. Apoptosis or cell death is
not the final stage in tissue development. The quick and effective removal of apoptotic cells by
tissue macrophages represents a vital process preventing "leak" of self-antigens and promoting the
production of proliferative/survival factors. One of the key requirements of apoptotic cell clearance
is the resolution of inflammatory conditions, which, as in the case of pregnancy, may have lethal
consequences. This review will focus on decidual macrophages and their role on apoptosis and cell
clearance during pregnancy.
Introduction
The role of the maternal immune system during preg-
nancy has focused mainly on the aspect of immune toler-
ance to the invading trophoblast and, therefore, fetus.
While this is a critical aspect of reproductive immunology,
it is also important to consider the function of the mater-
nal immune system in the promotion of implantation
and maintenance of pregnancy. This review will focus on
decidual macrophages and their role on apoptosis and
cell clearance during pregnancy.
Leucocytes at the implantation site
During normal pregnancy the decidua is populated by a
variety of leucocytes [1], however, cells of the innate
immune system seem to dominate this tissue since the
levels of lymphocytes are relatively low (1–3%) [2]. At the
time of implantation, many of the leucocytes are NK cells,
expressing a phenotype distinct from those found in the
periphery [3]. As gestation proceeds, NK cell numbers
decline and at term these leucocytes are absent [4]. Macro-
phages constitute 20–30% of the decidual cells at the site
of implantation [5,2,6,7] and unlike NK cells, remain
high throughout pregnancy [2,8]. This evidence suggests
that the innate immune system is not indifferent to the
fetus and may have a role not only in host protection to
infections, but also as important players in the feto-mater-
nal immune adjustment. An important aspect in this proc-
ess is the establishment of an adequate microenvironment
that will promote cell grow and will inhibit hazardous
inflammatory immune reactions.
Microenvironment of the implantation site
The local environment of the maternal-fetal interface is
characterized, not only by the cell types present, but also
by the soluble factors produced therein. The production
and effects of cytokines at the implantation site is impor-
tant for the regulation of trophoblast cell grow, differenti-
ation and invasion [9-11]. In normal pregnancies,
particularly at the maternal fetal interface, anti-inflamma-
tory, Th-2, cytokines predominate [12,13] and, therefore,
an appropriate balance between pro-inflammatory and
anti-inflammatory cytokines is thought to be crucial for
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determining the success or failure of a pregnancy [11]. It
is currently believed that for the continuous normal devel-
opment of pregnancy, production of inflammatory
cytokines such as, inerleukin-2 (IL-2), tumor necrosis fac-
tor-α (TNF-α) and interferon-γ (IFN-γ) is suppressed,
whereas production of anti-inflammatory cytokines such
as, IL-4, IL-6 or IL-10 is enhanced [12]. Placental and
decidual tissues from normal pregnancies have been
shown to express both pro- and anti-inflammatory
cytokines [14-17]. However, pro-inflammatory, Th-1,
cytokines appear to be potentially harmful to pregnancy
since excess production of TNF-α or IFN-γ has been asso-
ciated with pre-term delivery [17-20]. Similarly, low levels
of decidual IL-4 and IL-10 have been observed in women
suffering from unexplained recurrent abortions and where
spontaneous abortion has occurred during the first tri-
mester of pregnancy [19].
Immune cells, especially the macrophages, are a main
source of cytokines and growth factors and contribute to
the maintenance of the adequate balance between Th1
and TH2 cytokines at the placental bed.
Apoptosis and implantation
Apoptosis, or programmed cell death, is a natural mecha-
nism by which the body eliminates unnecessary or poten-
tially dangerous cells in order to maintain normal tissue
function. During implantation, apoptosis is important for
the appropriate tissue remodeling of the maternal decidua
and invasion of the developing embryo [7]. Although,
first trimester trophoblasts are resistant to Fas-stimula-
tion, apoptosis has been described in the trophoblast
layer of placentas from uncomplicated pregnancies
throughout gestation, suggesting that there is a constant
cell turnover at the site of implantation necessary for the
appropriate growth and function of the placenta [21-23].
In addition, the incidence of trophoblast apoptosis is
higher in third trimester villi compared to first trimester
placenta [24], suggesting that increasing placental apopto-
sis may be involved in the process of parturition. In preg-
nancies complicated by preeclampsia or intrauterine
growth restriction (IUGR), there is a greater incidence of
placental apoptosis in the first trimester, which is accom-
panied by insufficient trophoblast invasion [23,25]. Sev-
eral mechanisms, in addition to apoptosis, have been
described to limit extravillous trophoblast invasion into
the uteroplacental arteries. These include reduced expres-
sion of integrin α1β1 [26] decreased secretion of metallo-
proteinase (MMP-9) [27] and low cell surface
plasminogen activator activity, absent expression of vas-
cular endothelial cadherin [26] and reduced expression of
HLA-G [28]. The reduction of these factors, necessary for
trophoblast differentiation and invasion is compatible
with the hypothesis of increased apoptosis in IUGR
because it is known that once the cells, including trophob-
last, enter the apoptotic cascade this down regulate their
level of transcription [29]. This data suggests that the reg-
ulation of placental apoptosis is essential for the normal
physiology of pregnancy.
However, cell death by apoptosis is not the end of the
story, the clearance of apoptotic bodies represents a criti-
cal step in tissue homeostasis, preventing the release of
intracellular contents, which may cause tissue damage
and the possibility to initiate an inflammatory reaction.
Clearance of apoptotic cells
Different morphological changes accompany the execu-
tion of the apoptotic program. Cells first become round
and detach from their neighbors. Then, condensation of
both the nucleus and cytoplasm occurs without major
modification to the other intracellular organelles. Follow-
ing condensation, nuclear fragmentation and membrane
blebbing is observed, resulting in the formation of apop-
totic bodies with intact membranes. These morphological
changes are a translation of the biochemical modifica-
tions, mediated by the activation of the caspase cascade,
that are occurring inside of the cell.
Another important cellular change that occurs during
apoptosis is the redistribution of membranal proteins,
which will allow macrophages to recognize apoptotic cells
and direct the phagocytic process. Several receptors have
been implicated in the recognition and engulfment of
apoptotic cells [30,31], suggesting that the process of
phagocytosis is well regulated and functionally relevant.
As discussed above, implantation and trophoblast inva-
sion is characterized by a progressive, continuous induc-
tion of apoptosis in the maternal tissue surrounding the
fetus [32]. During this period, numerous macrophages are
present at the implantation site and this was originally
thought to represent an immune response against the
invading trophoblast. However, we propose that this may
not be the case. We suggest that macrophage engulfment
of apoptotic cells prevents the release of potentially pro-
inflammatory and pro-immunogenic intracellular con-
tents that occurs during secondary necrosis (See Figure 1).
Due to the allogenic nature of the placenta, this process
may be essential for the well being of the fetus. Trophob-
last cells are carriers of proteins, which are antigenically
foreign to the maternal immune system and if released, as
result of cell death, may initiate or accelerate immunolog-
ical responses with lethal consequences for the fetus.
Therefore, the appropriate removal of dying trophoblast
cells prior to the release of these intracellular components
is critical for the prevention of fetal rejection. Macro-
phages are a key cellular constituent of this process.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/119
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Effect of clearance of apoptotic cells by macrophages Figure 1
Effect of clearance of apoptotic cells by macrophages. A. Clearance of apoptotic cells induce the expression, by macro-
phages, of anti-inflammatory cytokines with protective effects on trophoblast survival and immunological tolerance. B. Changes 
in the cytokine milieu, owing to elevated levels of apoptotic bodies and inefficient clearance, will result in a pro-inflammatory 
microenvironment that in turn may result in changes in trophoblast resistance to Fas-mediated apoptosis and the maternal 
immune system
A
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Macrophages and clearance of apoptotic cells
The removal of cellular debris, generated as a result of
apoptosis, is a challenging task that must be performed to
maintain cellular homeostasis. This clearance process, far
from being the end, represents an active and coordinate
event which sends specific signals to the remaining cells,
either for survival or death [33]. The removal of apoptotic
bodies is neither a neutral nor a passive process, but rather
an active physiological event that may influence not only
immune responses, but also the proliferation and differ-
entiation of surrounding cells [31]. Consequently, a signal
from a macrophage to the wrong cell type may have pro-
found consequences for the normal physiology of the tis-
sue [34].
Recent reports have shown that binding to, and ingestion
of, apoptotic cells by phagocytes can result in active
immunosuppressive and anti-inflammatory responses.
Voll et al [35] found that monocyte secretion of TNFα was
inhibited, while production of TGFβ and IL-10 was
increased following co-culture of monocytes with apop-
totic lymphocytes. Furthermore, in vivo studies have
clearly demonstrated that the TGFβ released by macro-
phages ingesting apoptotic cells, has anti-inflammatory
effects in inflamed peritoneum and lungs [36]. Further-
more, the capacity for macrophages to influence cell death
may be regulated by the extent of uptake of apoptotic cells
[31]. Duffield et al demonstrated that the capacity of mac-
rophages stimulated with IFNγ and LPS or TNFα to induce
glomerular cells apoptosis could be suppressed by the
uptake of apoptotic cells [37].
Macrophages at the maternal-fetal interface
Histological analysis of normal placental beds shows the
presence of large number of macrophages, which are
localized, in the majority of the cases, in the vicinity of
apoptotic cells. Indeed, macrophages are one of the major
cell types in both the maternal and fetal compartments of
the uteroplacental unit [38]. In humans, during the first
weeks of implantation, macrophages are found in high
numbers in the maternal decidua and in tissues close in
proximity to the placenta [39]. Similarly in rodents, mac-
rophages accumulate at or near the implantation site [40].
The dense macrophage-infiltration at the maternal fetal
interface suggests that these cells are also involved in spe-
cific pregnancy-associated functions, and not only to per-
form their usual immunological tasks [41]. Hunt and co-
workers have implied that maternal macrophages assist in
the tissue remodeling necessary to accommodate expan-
sion of extraembryonic tissue [42]. However, macro-
phages are not merely scavengers of dying cells, but also
actively orchestrate apoptosis of unwanted cells during
tissue remodeling [31]. Macrophages synthesize and
secrete cytokines and growth factors, which govern the
local cellular and tissue interactions [39,42-44]. They also
respond to hormonal factors affecting their function and
survival [45,46].
Numerous findings indicate that the capacity for macro-
phages to influence cell death is regulated by the extent of
uptake of apoptotic cells [31]. For example, the cytolysis
of tumor cells by activated macrophages is inhibited by
the ingestion of apoptotic but not necrotic cells [47]. Sim-
ilarly, during embryo implantation, uterine epithelial
cells surrounding the blastocyst undergo apoptosis and
may form an anti-inflammatory environment by increas-
ing Th-2 type cytokines. This may explain the surprising
cohabitation of macrophages and trophoblast cells at the
implantation site. As stated earlier, the type of cytokines
produced by a macrophage depends on its activation state
[48]. We propose that during normal pregnancy, the
uptake of apoptotic cells suppresses activated macro-
phages from secreting pro-inflammatory cytokines such as
TNF-α and IFN-γ and promotes the release of Th-2 type,
anti-inflammatory and immunosuppressive cytokines
(Figure 1A). In pregnancies complicated with preeclamp-
sia or IUGR, activated macrophages secrete pro-inflamma-
tory cytokines such as TNF-α and IFN-γ and induce
apoptosis in extravillous trophoblast (Figure 1B). This
hypothesis is supported by a recent report of Pijnenborg
et al [49] who found a higher incidence of cell clusters
secreting TNF-α, probably macrophages, in the placental
bed of patients with severe forms of preeclampsia.
Macrophages are also located near the spiral arteries dur-
ing trophoblast invasion and transformation. Previous
studies, and ours, of placental bed specimens, demon-
strate changes in the distribution of macrophages during
pathologic conditions such as preeclampsia [50,51].
While in normal pregnancies macrophages are located in
the stroma surrounding the transformed spiral arteries
and extravillous trophoblast; in preeclamsia macrophages
are located within and around the spiral arteries separat-
ing them from the trophoblast cells. Their distribution
resembles a barrier between the invading trophoblast and
the spiral arteries (See Figure 2). In addition, Resiter et al
[51] have reported that macrophages residing in excess in
the placental bed of preeclamptic women are able to limit
extravillous trophoblast invasion of spiral arteries seg-
ments through apoptosis mediated by the secretion of
TNFα. We propose a differential role for uterine macro-
phages during trophoblast invasion/differentiation,
according to their stage of activation. In normal pregnan-
cies, macrophages function as support cells by facilitating
trophoblast invasion through the placental bed. In patho-
logic conditions, macrophages function as a barrier for
trophoblast invasion and differentiation by inducing tro-
phoblast apoptosis and therefore preventing spiral arter-
ies transformation (Figure 2).Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/119
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Role of apoptotic cell phagocytosis in pregnancy-
associated diseases
The anti-inflammatory action of phagocytic clearance of
apoptotic cells may be perturbed in disease processes.
Anti-phospholipid antibodies in apoptotic cells may bind
to surface expressed Fc receptors on macrophages result-
ing in secretion of pro-inflammatory cytokines such as,
TNF-α, [52]. Therefore, during pregnancy, cytokine pro-
duction by macrophages and other cells at the maternal-
fetal interface may be drastically altered [53]. The results
of our studies are in concert with this concept and indicate
that enhanced levels of pro-inflammatory macrophage
products increase Fas expression and enhance trophoblast
sensitivity to Fas-mediated apoptosis [54,55].We have
also demonstrated that the factors produced as a result of
phagocytosis of apoptotic cells have a significant impact
on viable trophoblast cells and that this is dependent on
the levels of apoptotic cells. We have developed an in vitro
system consisting of monocyte-derived macrophages and
apoptotic first trimester trophoblast cells. We find that
macrophages successfully engulf apoptotic trophoblast
cells in vitro (Figure 3). In addition, trophoblasts cells
treated with conditioned media collected from monocyte-
derived macrophages, co-cultured with low numbers of
apoptotic trophoblast expressed the active form of XIAP,
an inhibitor of apoptosis, and showed no caspase-3 acti-
vation. This supports the hypothesis that clearance of
apoptotic trophoblast cells by macrophages may protect
the expanding trophoblast population from cell death
during pregnancy. However, trophoblasts cells treated
with conditioned media collected from macrophages co-
cultured with high levels of apoptotic trophoblast cells
expressed the inactive from of XIAP and the active forms
of caspase-3 (Figure 4). This suggests that an excess of
Differential Distribution of macrophages in normal pregnancy and pregnancy complicated with preeclamsia and IUGR Figure 2
Differential Distribution of macrophages in normal pregnancy and pregnancy complicated with preeclamsia 
and IUGR. While in normal pregnancies macrophages are located in the stroma surrounding the transformed spiral arteries 
and extravillous trophoblast (A) ; in pre-eclampsia macrophages are located within and around the spiral arteries separating 
them from the trophoblast cells (B). In the normal condition, macrophages promote trophoblast survival; while in the patho-
logic state induce apoptosis
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apoptotic bodies may stimulate macrophages to produce
pro-apoptotic factors. Alternatively, apoptotic cells
undergoing secondary necrosis as a result of a failure of
efficient clearance may directly influence trophoblast cell
viability. Therefore, an increase in the levels of trophob-
last apoptosis, possibly a result of infection, may initiate
an inflammatory event that will further promote trophob-
last cell death preventing normal trophoblast invasion,
spiral arteries transformations and fetal survival. Such
may be the case in pathologies such as preeclampsia and
IUGR.
Conclusion
Apoptosis or cell death is not the final stage in tissue
development. The quick and effective removal of apop-
totic cells by tissue macrophages represents a vital process
preventing "leak" of self-antigens and promoting the pro-
duction of proliferative/survival factors. One of the key
requirements of apoptotic cell clearance is the resolution
of inflammatory conditions, which, as in the case of preg-
nancy, may have lethal consequences. The clearance of the
apoptotic trophoblasts at the implantation site by macro-
phages and its effect on the well being of the placenta
throughout pregnancy is a novel area, which warrants
investigation. The field of apoptotic cell clearance is
Macrophages phagocytose apoptotic first trimester trophoblasts Figure 3
Macrophages phagocytose apoptotic first trimester trophoblasts. Apoptotic trophoblasts cells (green) are engulfed 
by THP-1-differentiated macrophages (red).Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/119
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beginning to flourish, and many questions remain
unanswered.
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